Latest filing published 18 Jul 2019 for ARATANA THERAPEUTICS, INC..
No signal scores available.
David L. Brinkley is a declared insider of Aratana Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 24 June 2016 to 18 July 2019, the count stands at 5 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 18 July 2019: a transaction, in Aratana Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations